Varicella-Zoster Virus Myocarditis: Early Clinical Diagnosis and Outcome.

Autor:	Cherukuri ASS; Geriatrics, Michigan State University, East Lansing, USA., Belay NF; Geriatrics, Michigan State University, East Lansing, USA., Nasereldin DS; Geriatrics, Michigan State University, East Lansing, USA., Mohammed DO; Geriatrics, Michigan State University, East Lansing, USA., Mohamed S; Geriatrics, Michigan State University, East Lansing, USA., Elkhazeen A; Geriatrics, Michigan State University, East Lansing, USA., Ghobriel NG; Geriatrics, Michigan State University, East Lansing, USA., Alatta L; Geriatrics, Michigan State University, East Lansing, USA., Alsafi W; Geriatrics, Michigan State University, East Lansing, USA., Abdalla Y; Geriatrics, Michigan State University, East Lansing, USA., Brry G; Geriatrics, Michigan State University, East Lansing, USA., Abdelrahman N; Family Medicine - Geriatrics, Michigan State University College of Human Medicine, East Lansing, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Apr 23; Vol. 15 (4), pp. e38015. Date of Electronic Publication: 2023 Apr 23 (Print Publication: 2023).
DOI:	10.7759/cureus.38015
Abstrakt:	Varicella-zoster virus (VZV) is a viral infection that causes chickenpox and shingles. Although it is usually self-limiting, it can lead to severe complications, especially in pediatric and immunocompromised patients. VZV was first discovered as a cause of myocarditis in 1953. In this review article, we aim to investigate the early clinical diagnosis of myocarditis in VZV infections and the efficacy of the VZV vaccine in preventing myocarditis. The literature search was done using PubMed, Google Scholar, and Sci-Hub databases. A high VZV mortality rate was noted among adults, infants, and immunocompromised patients. The early diagnosis and treatment of VZV myocarditis can reduce mortality. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Cherukuri et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu